We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Senate Passes USMCA Trade Deal, Broadening Opportunities for Biologics
Senate Passes USMCA Trade Deal, Broadening Opportunities for Biologics
The Senate voted 89-10 yesterday to pass the United States-Mexico-Canada trade agreement, sending it to the president’s desk as generic and biologic drug advocates cheered the removal of a 10-year biologic exclusivity provision.